Clinical Trials
11
Active:0
Completed:6
Trial Phases
3 Phases
Phase 1:3
Phase 2:7
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 2
7 (63.6%)Phase 1
3 (27.3%)Phase 3
1 (9.1%)A Study of Apabetalone in Subjects With Long -COVID
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-18
- Lead Sponsor
- Resverlogix Corp
- Target Recruit Count
- 200
- Registration Number
- NCT06590324
- Locations
- 🇯🇴
The Speciality Hospital, Amman, Jordan
🇸🇦MNGHA- King Abdulaziz Hospital, Al Mubarraz, Saudi Arabia
🇦🇪Al Kuwait Hospital, Dubai, United Arab Emirates
An Open-Label Study of Apabetalone in Covid Infection
- First Posted Date
- 2021-05-20
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Resverlogix Corp
- Target Recruit Count
- 1
- Registration Number
- NCT04894266
- Locations
- 🇨🇦
University of Alberta, Edmonton, Alberta, Canada
Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease
- First Posted Date
- 2017-07-25
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Resverlogix Corp
- Registration Number
- NCT03228940
- Locations
- 🇨🇦
Queen Elizabeth II Health Sciences Centre, Victoria General Site, Halifax, Nova Scotia, Canada
A Two-Part Phase 2a Study of RVX000222 in Patients With End-Stage Renal Disease Treated With Hemodialysis
Phase 1
Not yet recruiting
- Conditions
- Kidney Failure, Chronic
- Interventions
- Drug: Placebos
- First Posted Date
- 2017-05-19
- Last Posted Date
- 2023-11-15
- Lead Sponsor
- Resverlogix Corp
- Target Recruit Count
- 44
- Registration Number
- NCT03160430
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
Phase 3
Completed
- Conditions
- Diabetes Mellitus, Type 2Coronary Artery Disease
- Interventions
- First Posted Date
- 2015-10-26
- Last Posted Date
- 2021-08-20
- Lead Sponsor
- Resverlogix Corp
- Target Recruit Count
- 2425
- Registration Number
- NCT02586155
- Locations
- 🇦🇷
Instituto de Investigaciones Clinicas Bahia Blanca, Bahía Blanca, Argentina
🇦🇷Bioclinica Buenos Aires, Buenos Aires, Argentina
🇦🇷Centro Privado de Enfermedades Cardiovasculares, Buenos Aires, Argentina
- Prev
- 1
- 2
- 3
- Next
News
No news found